BERNADETTE ANGELES: Open Payments
NPI 1093747149 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,050 in 138 payments from 16 companies in 2025. Trend: 2023 $2,077 · 2024 $2,339 · 2025 $3,050
Food & beverage: $3,050
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 18 | $447 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $432 |
| Neurocrine BioSciences, Inc. | 18 | $389 |
| Janssen Pharmaceuticals, Inc | 17 | $278 |
| Lundbeck LLC | 11 | $270 |
| Teva Pharmaceuticals USA, Inc. | 10 | $259 |
| Alkermes, Inc. | 10 | $226 |
| Otsuka America Pharmaceutical, Inc. | 9 | $181 |
| ABBVIE INC. | 7 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
Products named: REXULTI, FANAPT, CAPLYTA, INGREZZA, SPRAVATO, AUSTEDO XR, ARISTADA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
